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The number of chronic wound patients is increasing world wide, despite the fact that the last twenty years have seen major innovations in wound healing. Unfortunately this also means a steep rise in the number of lower limb amputations due to previous tissue loss.
Chronic wounds are a growing challenge due to demographic changes and increased risks of atherosclerosis and diabetes. In developing countries the prevalence of diabetes is about 5-7%, and it is estimated that 15% of all diabetic foot ulcers will result in amputations ( Figure   1 ). Both tissue loss and amputations have an enormous impact on one's everyday life resulting in social isolation, loss of independence, psychological stress and increased health costs for the patient and the society as well. These health costs already present a significant economic problem for health care providers, and with the patient numbers increasing they forecast a boom in expenses in the near future. The abundance of wound care methods and products resulted in an information boom regarding wound healing, making every day decision making harder. Treating a wound properly now equals to establishing a complex care strategy for the patient with the involvement of a multidisciplinary wound care team.
Mechanism of wound healing
The normal wound healing process takes around 7 -14 days to complete. It has three main phases: inflammation, proliferation and remodeling with wound contraction. During the inflammation phase, various vasoactive mediators are excreted by thrombocytes due to coagulation, activated complement pathways and injured parenchymal cells. These substances recruit inflammatory leukocytes, which clean the wounded area. At the same time, the infiltrating monocytes become activated macrophages and release growth factors such as platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF), which initiate the formation of granulation tissue. Macrophages also express colony-stimulating factor 1 (CSF-1), a cytokine necessary for the survival of monocytes and macrophages, tumor necrosis factor α (TNF-α), a potent inflammatory cytokine, transforming growth factor β (TGF-β) and interleukin-1 (IL-1). Macrophage-depleted animals exhibit defective wound repair and therefore macrophages seem to be essential in the transition between inflammation and repair (Clark et al., 1996; Toumi et al., 2006) .
The phase of tissue formation is characterized by re-epithelialization and neoangiogenesis. During re-epithelization, epidermal cells located at skin appendages and at wound edges undergo marked phenotypic alterations including the retraction of tonofilaments, the dissolution of desmosomes, and cytoplasmic actin filament formation. Migrating epidermal cells separate the non-viable and viable parts of wounds. This process is determined by integrin receptors expressed on the surface of migrating cells. The extracellular matrix viability primarily depends on the production of collagenase and plasminogen activator. The processes of migration and proliferation are attributed to the absence of neighbor cells, locally released growth factors and especially fibroblast growth factors (FGFs) and their receptors (Werner et al., 1994; Paladini et al., 1996; Singer and Clark, 1999) .
The formation of new blood vessels is necessary to sustain the newly formed granulation tissue. The induction of angiogenesis was initially attributed to FGFs, but several other molecules have also been found to exert angiogenic activity, such as VEGF, TGF-β, angiogenin, angiotropin, angiopoietin 1 and thrombospondin (DiPietro et al., 1996; Nissen et al., 1998) . A low oxygen tension and elevated levels of lactic acid may also stimulate angiogenesis (Laurens et al., 2006) .
Fibroblasts residing in the dermis are responsible for the synthesis, deposition and remodeling of the extracellular matrix. The provisional extracellular matrix is gradually replaced by a collagenous matrix. Once collagen matrix has been deposited in a wound, the granulation tissue is replaced by a relatively acellular scar. Dysregulation of these processes results in fibrotic disorders such as keloid formation, morphea and scleroderma (Singer and Clark, 1999; Holmbeck et al., 2006) .
The last phase of wound healing is tissue remodeling: during the second week of healing, the fibroblasts assume a myofibroblast phenotype characterized by large bundles of actin filaments. The appearance of myofibroblasts corresponds to the commencement of connective tissue compaction and the contraction of the wound. TGF-β and PDGF are essential factors for contraction. Collagen remodeling during the transition from granulation tissue to scar is controlled by proteolytic enzymes, matrix metalloproteinases, which are secreted by macrophages, epidermal cells, endothelial cells and fibroblasts (Holmbeck et al., 2006) . In the case of acute wounds normal wound healing is described as a cascade of physiological events resulting in full epithelisation. In chronic wounds these events often take place not one by one, but at the same time. A chronic wound is defined as a break in the skin of long duration (more than 6 weeks). Analyzing a chronic wound, one must attempt to determine which aspect of the healing process gone wrong and why. It should be carefully assessed whether it is the result of local or systemic microenvironmental factors. With this approach, chronic wound can be considered as a symptom of an underlying disease.
For most cases successful wound healing is based on two pillars (goals): treating the underlying cause or disease behind the chronic wound and adequate local wound care resulting in a wound bed ready for epithelisation. Evidently, accomplishment of only one of these two goals will never result in long term success.
The non-healing wound: could leg ulcers be hereditary?
The ulceration of the leg is a multifactorial disorder with several known and yet unknown environmental and genetic factors contribute to its etiology. To study the genetic factors involved in the mechanism of leg ulcer development and to minimize statistical bias, we have chosen one of the major homogenous subgroup of leg ulcers, therefore our genetic studies were carried out on patients with venous leg ulcer. The complexity of venous leg ulcer pathogenesis is increased by the fact that in the majority of the cases its development has polyetiological origin. Besides environmental factors, several predisposing genetic factors have already been shown to be associated with venous leg ulcer susceptibility such as the presence of certain gene polymorphisms and gene expression abnormalities (Table 1. ). The known genetic factors predisposing to venous leg ulcer development are the followings factor V Leiden mutation, prothrombin gene G20210A mutation, antithrombin deficiency, activated protein C resistance, protein S deficiency, hyperhomocysteinaemia and abnormal TGF-β type 2 receptor expression (Munkvad et al., 1996; Peus et al., 1997 
The role of fibroblast growth factor receptor 2 in wound healing
The isoforms of the proteins coded by the fibroblast growth factor receptor 2 gene (FGFR2), plays complex roles in the process of wound healing and are active in all phases. In the process of re-epithelization, the control of keratinocyte proliferation is attributed to FGFR2-IIIb signaling through mediation of the effects of FGF-7 keratinocyte growth factor 1 (KGF-1) and FGF-10 (KGF-2; Maas-Szabowski et al., 2001) , while the induction of woundrepair-associated neoangiogenesis is attributed to FGFR2-IIIc signaling.
Upon injury-induced IL-1 stimulation, FGF are expressed primarily in fibroblasts during the tissue formation phase of wound healing. After being excreted, the FGFs diffuse into the upper layer of the skin and bind specifically to their receptor, FGFR2-IIIb keratinocyte growth factor receptor (KGFR). Due to the receptor-ligand interactions between FGFs and FGFR2-IIIb, signal transduction mechanisms are initiated, and hence the keratinocytes commence to proliferate (Maas-Szabowski et al., 2001) .
During neoangiogenesis, macrophages are located in the granulation tissue and release
FGFs. The FGFs bind to their receptor, FGFR2-IIIc, and stimulate the endothelial cells. Due to this receptor-ligand interaction, endothelial cells excrete plasminogen activator and procollagenase. Plasminogen activator converts plasminogen to plasmin and procollagenase to active collagenase, and these proteases digest the basement membrane of blood vessels.
The fragmentation of basement membrane allows endothelial cells to migrate and form new blood vessels at the injured site (Singer and Clark, 1999 ).
The role of tumor necrosis factor α in wound healing
Tumor necrosis factor α (TNF-α) is a potent pleiotropic, pro-inflammatory cytokine that belongs to the TNF superfamily. In the course of an injury or an infection, the soluble TNF-α is released from macrophages and endothelial cells due to IL-1 and/or bacterial endotoxin stimulation and binds to its receptors: the TNF receptor 1 (TNFR1) and 2 (TNFR2), both of which have cell surface and soluble forms as well (Hotamisligil et al., 1997) .
TNF-α mediates a number of biological processes, including lipid metabolism, coagulation, insulin resistance, endothelial functions and wound healing (Crist et al., 2004) .
Moreover, it plays a key role in the inflammation phase of normal wound healing. As growing numbers of evidences suggest, TNF-α has an essential function in the healing of pathological wounds such as venous leg ulcers. Wallace and Stacey (1998) demonstrated that the level of TNF-α is down-regulated in the wound fluid from non-healing venous leg ulcers as compared with healing venous leg ulcers. Further, it has recently been proved that the topical application of TNF-α antibody (infliximab) improves the healing of chronic wounds (Streit et al., 2006) .
The role of syndecan-4 in wound healing
Syndecan-4 (SDC4) is a heparan sulfate proteoglycan expressed on the surface of most adherent mammalian cells. It is essential for cell-matrix junction formation such as focal adhesions. SDC4 interacts with integrins in response to fibronectin and modulates cell behavior such as adhesion, migration, and proliferation. A considerable amount of evidence suggests the complex role of SDC4 in wound healing. Immunodepletion of SDC4 in wound fluid reduces proteolytic activity and indicates that proteases in the wound environment are regulated by interactions with SDC4. During granulation tissue formation, the expression of SDC4 is transiently increased in human and murine neonatal skin, which correlates with the up-regulation of proliferation. SDC4 knock-out mice show delayed wound healing due to failure to form granulation tissue and impaired angiogenesis. With a yet unknown mechanism, SDC4 modulates cytoplasmic and extracellular interactions of growth factor tyrosine kinase receptors. In addition, platelet-derived growth factor, a well-known chemotactic factor in the inflammatory phase of wound healing, strongly up-regulates the expression of SDC4 in fibroblasts. So far, there is only one study in the literature that compares SDC4 expression profiles in skin biopsy samples collected from the wound edge and from uninvolved skin of 11 chronic venous leg ulcer patients. It was demonstrated that the expression of SDC4 was mostly pericellular in samples that derived from the wound edge, while it was mainly intracellular in the uninvolved skin samples. Whether there are abnormalities in the expression profile of SDC4 in intact skin of venous leg ulcer patients compared with healthy individuals has not been demonstrated by the authors.
The role of neuropilin-1 in wound healing
Neuropilin-1 (NRP1) is a transmembrane receptor for semaphorin and VEGF isoforms. It is expressed in neurons, endothelial cells, and also in keratinocytes and plays versatile roles in angiogenesis, axon guidance, cell survival, migration, and invasion. In vivo and in vitro dermal wound repair models demonstrated that NRP1 is a co-receptor of vascular endothelial growth factor receptors (VEGFR) and is involved in the VEGF-mediated angiogenesis associated with dermal wound repair. However, NRP1 binds semaphorin in the epidermis in a plexin-dependent manner and plays a role in the regulation of keratinocyte migration. Earlier studies analyzed the role of NRP1 in the process of normal wound healing, but not in diseases with wound-healing abnormalities such as venous leg ulcer. Increasing data in the literature suggest a connection between NRP1 and SDC4. It has been reported that NRP1 binds FGF2 and modulates its signaling via its receptor, FGFR2, while SDC4 is a wellknown co-receptor of FGFR2 with the binding ability both to FGF2 and FGFR2, and its overexpression leads to enhanced FGF2 signaling. Furthermore, NRP1 mediates the effects of VEGF and enhances the angiogenic signal cooperatively with VEGFR2, while SDC4 is upregulated in parallel with VEGF in fibroblasts and endothelial cells cultured under hypoxic conditions.
Principles of wound care

The non healing wound: common causes
Common causes of chronic wounds are basically of two types: vascular and non vascular. Vascular causes could affect the venous, arterial and lymphatic system. Non vascular causes are mainly linked to diabetic neuropathy, pressure ulcers, infection, immunological defects and malignancies.
Venous ulcers account for the majority of all lower limb wounds. It is estimated, that around 2-3% of the adult population is affected (Phillips et al., 1991) . In general arterial ulcers are a consequence of inadequate blood supply to the skin, resulting in tissue necrosis. Arterial disease is present in about 25% of patients with leg ulcers (Baker et al., 1992) . Mixed arterial and venous ulcers are also not uncommon. The most common cause is atherosclerosis (often called ischemic arterial ulcer), although diabetic arterial and renal arterial ulcers are also common. History of the patients contains claudication, rest pain, ulceration and gangrene. On physical examination in ischemic arterial ulcers we find absent or hardly detectable pulses, cold feet, pale skin and painful ulcers on the finger tips. Management should focus on endovascular or surgical arterial restoration.
Lymphatic ulcers form on the basis of lymphoedema, which can be primary (hereditary) and secondary. Secondary lymphoedema is always the cause of either excess lymph production or an obstruction in lymph drainage. History of the patient usually includes previous inflammation, trauma of the limb, possibly a malignancy. On physical examination we find swelling, in earlier stages pitting, in advanced forms non-pitting oedema and in severe cases an elephantine look of the affected limb. Liposuction in non pitting lymph-and lipoedema and, in very rare cases, microsurgical procedures for the anastomoses of the lymphatic and venous vessels could also be a treatment of choice.
Diabetic patients have 25% lifetime risk of developing a foot ulcer (Young et al., 1993; Boulton et al., 1988) . It is estimated that up to 15% of all foot ulcers will result in amputations (Frykberg et al., 2000) . Diabetic foot ulcers are usually the consequences of diabetes associated peripheral neuropathy and vascular disease affecting both the macro-and microvasculature. Peripheral motor neuropathy will result in atrophy of the intrinsic muscles of the foot resulting in structural deformities. Should this be coupled with sensory neuropathy it is only the matter of time for wound formation due to unfelt mechanical stress. In most patients a callus will form, clearly marking pressure points on the foot. Wound healing is usually worsened by impaired immunological functions, poor blood sugar control, poor tissue oxygenisation due to loss of autonomous regulation and vasomotion of the microvasculature. Rare type of ulcers, atypical location, morphology and history pose interesting situations. As a central rule, if an ulcer appears at an atypical location, with atypical history and morphology, skin biopsy from the periwound area has to be taken. Rare cases of non healing wounds should always be diagnosed with histological evaluation. In most cases the underlying disease is malignancy or an immunological disorder.
Advanced local wound care
The basic goal of local wound care is to prepare a wound bed ready for epithelisation in the shortest, safest, pain free manner in the most cost-effective possible way. This simple goal has been around since ancient Greek physician Galen of Pergamun who noted that wounds heal optimally in a moist wound environment. For some reason this ancient principle was forgotten and drying the wound bed was the main goal of local wound care until the 1960s. The latter half of the 20 th century saw enormous research and development in the field of moist wound care. This subsequently led to the birth of modern, moist wound care dressings. The main goal of these wound dressings is to maintain and protect a moist wound environment with the possible capability to absorb the excess exudates to prevent maceration.
There are numerous dressing categories used today and the main types for the wound surface are: gauzes, films, hydrogels, hydrocolloids, alginates, foams, collagens and silver or iodine containing antimicrobial dressings. Besides the use of modern moist wound dressings a wide array of wound care methods have been developed to solve common wound bed disorders.
Aims
Genetic studies
Most of the chronic leg ulcers can be classified into one of the following categories described before. However, some of the wounds fail to heal even after causative treatments.
These leg ulcers are considered as highly recalcitrant forms and increasing number of evidence suggest that they are the consequences of combined (acquired and inherited) etiological factors or multi-etiological factors (Fowkes et al., 2001; Abbade et al., 2005) . In these cases, besides the characteristic acquired etiological factor such as venous insufficiency, there is a putative inherited etiological factor thet al.so contributes to the mechanism of delayed or pathologic wound healing and thus to the development of leg ulcer. Therefore the delineation of the molecular mechanisms of pathologic wound healing might lead to the development of causative treatment opportunities for these therapy-resistant forms as well.
The aims of our genetic studies were to identify common single nucleotide polymorphisms (SNP), which are associated with leg ulcer development and gene expression abnormalities related to pathologic wound healing. After completion of the PCR reactions end-point detection was performed with an ABI Prism 7000HT Sequence Detection System. The statistical significance of the differences between data distributions was determined by using the Chi 2 probe and a probability level P<0.05 was considered statistically significant.
SNP detection with the PCR-RFLP method
Blood samples were collected from all participants (n=282), DNA was isolated by a standard proteinase K digestion method (Eppendorf AG, Hamburg, Germany). The TNF-α -308 G/A SNP was genotyped by a PCR with restriction fragment length polymorphism method: 100 ng of genomic DNA was used for PCR amplification and a 147-nucleotide region of the TNF-α promoter harboring the SNP was amplified by PCR, using the following primers: forward 5' -GAGGCAATAGGTTTTGAGGGCCAT -3', reverse 5' -GGGACACACAAGCATCAAG -3'. Restriction enzyme digestion -with NcoI (Fermantas, Vilnius, Lithuania) -was performed to distinguish the -308 G/A alleles, using 10 µl of the PCR products, run on 5% Nusieve agarose gels (Cambrex, Berkshire, UK) and photographed.
The amplified wild-type (GG) PCR product was cut at one position by NcoI, resulting in 121and 26-nt bands, the amplified homozygote mutant (AA) PCR product was not cut; therefore, the original 147-nt PCR product was detected, and the heterozygote mutant genotype was characterized by a pattern of 147-, 121-and 26-nucleotidet products.
Gene expression studies
Analysis of gene expression at mRNA level (real-time RT-PCR)
Total RNA was isolated from samples through the use of the TRIzol reagent, following the instructions of the manual. cDNA was generated with oligo(dT) and random Laboratories) in an iCycler (Bio-Rad Laboratories).
Analysis of gene expression on the protein level (Western blot analysis)
Total protein extracts were prepared from the skin biopsy samples using TRIzol reagent according to the instructions of the manual. In order to verify the equivalent loading of proteins in the wells, the following procedure was carried out: based on the measured density OD 280 , the protein concentration of each sample was calculated, and the samples were Besides FGFR2-IIIb, the protein expression of a differentiation marker, K10 was also detected with a mouse monoclonal antibody (Dako A/S, Glostrup, Denmark) in a dilution of 1:500. Alkaline phosphatase-conjugated goat anti-rabbit IgG and anti-mouse IgG (Sigma-Aldrich) were used as secondary antibodies at a dilution of 1:4000 dilution in the blocking buffer for 2 h at room temperature. The blots were developed by using 5-bromo-4-chloro-3indolyl phosphate/nitroblue tetrazolium as substrate (Sigma-Aldrich).
Statistical analysis
Statistical analysis, on the groups of leg ulcer patients and leg ulcer-free controls, was carried out according to the rules of case-control allelic association study design. The statistical significance of the association between the mRNA or protein expression profiles of the different genes and venous leg ulcer development was assessed by one-way ANOVA for two independent samples. The statistical significance of the association between the examined SNPs of FGFR2 and venous leg ulcer was determined with the Chi 2 probe. The Bonferroni correction for the multiple hypothesis of the analyzed different SNPs (n=5) was also defined.
The statistical significance of the association between the -308 TNF-α SNP and venous leg ulcer was calculated by means of the Fisher Exact Probability Test. To allow comparison with the findings of Wallace et al. (2006) , logistic regression analysis was also carried out. For all SNPs, odds ratios (ORs) with 95% confidence intervals (CIs) were also determined. All statistical analyses were carried out through the use of VassarStats (http://faculty.vassar.edu/lowry/VassarStats.html).
Local wound care studies
Autologous skin cell therapy
Treatment of chronic leg ulcers and extensive two and three degree burns unite in the same goal: to provide the absent autologous skin cells. This is accomplished by tissue engineering, a new and interdisciplinary field that aims to solve the critical medical problems of tissue loss and organ failure. In today's practice a small skin specimen is taken from the patient as a full thickness sample from the groin, or as a split thickness graft from the upper leg or arm. Epidermal cell suspension is prepared and plated in vitro. Within two to three weeks and following several passages a pure keratinocyte culture is established which then is transplanted into the wound bed. Keratinocytes attach to the wound bed and produce a wide array of growth factors and fasten the healing process. Since the grafted keratinocytes are autologous there is no immunological reaction involved in this transplantation technique.
Hair follicles contain a higher number of undifferentiated keratinocytes, thus keratinocyte cultures established from the hairy scalp should have a better mitotic potential, making them more suitable for keratinocyte transplantation.
Human skin biopsy samples
We took biopsies from six patients after approval of the study protocol by the Ethical In a series of experiments we compared the effect of FBS, EGF and BPE separately and together on the in vitro growth of melanocytes. To prepare a medium free of animal derivatives we substituted FBS with the patient's autologous serum and left out BPE.
Culturing with chemical mitogens was performed with the addition of 12-O-tetradecanoyl phorbol-13-acetate (TPA) 10 ng/ml (Sigma) to the complete Mel-mix medium.
Cell culture techniques
Adult epidermal melanocytes were isolated and cultured from breast or trunk skin specimens of healthy Caucasian donors undergoing plastic surgery. Skin specimens were first washed in Salsol A solution (Human Rt, Gödöllő, Hungary) supplemented with 2% antibiotic, antimycotic solution (Sigma). The subcutis and part of the dermis was removed and the tissue was cut into small strips. Overnight incubation in Dispase solution (Grade II, Roche Diagnostics, Mannheim, Germany) was carried out at 4°C to separate the dermis from the epidermis (Kitano et al., 1983) . The epidermis was peeled of the dermis next day. To prove that the use of dispase prevents fibroblast contamination, we isolated RNA both from the epidermis and the dermis after dispase treatment and performed real-time RT-PCR using primers specific for COL1A2, the gene that encodes for the alpha 2 chain of type I collagen.
We could not detect COL1A2 gene expression in the epidermal sample. Thus, the use of dispase prevents fibroblast contamination in the epidermal cell cultures. The epidermis was put into 0.25% trypsin (Gibco) for 30 minutes at 37°C. Following trypsinization, the epidermis was mechanically torn apart and vigorously washed to release epidermal cells. The epidermal cell suspension was filtered through a 100 µm nylon mesh (BioDesign, Saco, Maine, USA) and centrifuged at 200g for 10 minutes at 4°C. Epidermal cells were then placed into 75 cm 2 tissue culture dishes (Corning Incorporated, Corning, NY, USA) at a cell density of 4x10 5 cells/cm 2 . Cells were washed with fresh culture media 12-18 hours after seeding to remove floating cells from the culture. Fresh culture media was put on cells three times weekly. Primary cultures reached ~90% confluence in 7-9 days. Confluent primary cultures were treated with 0.05% EDTA in PBS and cells were harvested by a short, 1-2 minute trypsinization with 0.01 % trypsin (Gibco). Trypsinization of cultured epidermal cells provides an almost 100% pure melanocyte culture sometimes even after the first passage, but always after the second, because melanocytes release from the culture dish much faster than keratinocytes ( Figure 3 ). Harvested cells were divided into two equal parts at passages.
Cultures were grown at 37°C in humidified atmosphere containing 5 % CO 2 . 
Measurement of cell growth
The growth of cultured melanocytes was measured using a rapid colorimetric assay, which determines cell numbers (Mosmann et al., 1983) 1.1.1. SNP in the 3' untranslated region of the FGFR2 gene (2451A/G) Comparison of the SNP data on venous leg ulcer patients (n=82) Figure 6 ).
SNP in the promoter region of the TNFα gene (-308 G/A)
Our results revealed that the association between the -308 G/A TNFα SNP and venous leg ulceration depends strongly on the number of obese individuals enrolled in the study.
Another potential factor involved in venous leg ulcer development could be the presence of the A nucleotide in the -308 TNFα SNP, though our data suggest that this association with leg ulceration is secondary and the primary association is probably with obesity ( Figure 6 ). 
Gene expression abnormalities
Syndecan 4 (SDC4), a heparan sulfate proteoglycan, and neuropilin 1 (NRP1), a transmembrane receptor, are both involved in normal wound healing, but little is known about their possible role in venous leg ulcer pathogenesis. We aimed to investigate whether there are any expression abnormalities and/or gene polymorphisms of SDC4 and NRP1 associated with venous leg ulcer. SDC4 showed significantly lower mRNA and protein expression levels in the uninvolved dermis of venous leg ulcer patients (n=15) as compared with controls (n=15;
P=0.0136), while NRP1 showed no expression abnormalities. We hypothesize that SDC4 may play an essential role not only in the inflammation and tissue formation phases of normal wound healing but its expression abnormalities observed in the uninvolved dermis of venous leg ulcer patients may contribute to venous leg ulcer development. To study the effect of TPA on the in vitro cell growth of normal human epidermal melanocytes, melanocytes cultured in complete Mel-mix medium until the 4 th passage were harvested, then plated into 96-well plates at a density of 5x10 3 cells/well. Cells were then grown for 72 hours either in serum-and supplement-free Mel-mix or in serum supplemented
Mel-mix medium with and without 10 ng/ml TPA. TPA alone increased the number of viable cells, in the cultures by 15.2 ± 8.5%, while the addition of 2.5% FBS alone caused a 42.3 ± 4.1% increase in cell number compared to the supplement-and serum-free control medium. TPA and 2.5% FBS together showed a 50.4 ± 20.6% increase in cell number. When compared to the supplement-free Mel-mix medium neither FBS, nor TPA or the two together had a significant growth stimulatory effect on the cells (ANOVA, P<0.05).
To determine cell growth and the effect of different growth factors in our chemical mitogen-free Mel-mix medium, a series of MTT assays were carried out using different culture conditions (Figure 8 ). Melanocyte growth in the 4 th passage was measured at three time points during an 8-day long culture period. The following culture conditions were tested: to FBS, AHS is at least as good, even somewhat better growth supplement for melanocytes.
Although the highest increase in cell numbers occurred in the medium that contained AHS and both EGF and BPE, AHS together with only the recombinant EGF resulted in a slightly lower increase in cell numbers. 
Hairy scalp the ideal donor site for split thickness and autologous keratinocytemelanocyte transplantation
Analyses of freshly isolated keratinocytes from hairy scalp skin showed that the percentage of the p63 positive cells was significantly higher (39.8±12.0%) as compared to upper leg (31.7±8.3%, P=0.007) or groin (27.8±16.0, P=0.03). The percentage of K1/K10 negative cells was also significantly higher (52.6±10.2%) than in the case of keratinocytes separated from groin (35.4±4.5%, P=0.018) or from the upper leg (36.1±3.2%, P=0.028).
Moreover hairy scalp yielded a higher number of epidermal cells from the same size of skin specimen (Figure 9 ). 
Autologous keratinocyte transplantation in wound healing
A time as short as two weeks of culturing was sufficient to achieve the suitable cell number for transplantation (3x10 6 /100 cm 2 ) in the case of cells derived from hairy scalp biopsies, compared to 3 to 4 weeks in case of the groin and the upper leg biopsies.
We used autologous keratinocyte transplantation in 18 patients. The gender ratio was 12 female/6 male. The mean age was 65 years. All transplanted ulcers were of venous origin.
Transplantation was only performed once using the Baxter Tissucol ® system (Figure 10 ). 
Split-skin grafting from the hairy scalp in wound healing
Due to the results of autologous keratinocyte transplantation from the hairy scalp, we decided to use the hairy scalp as a donor site for split skin grafting of chronic wounds. Hairy scalp is ideal because of the abundant number of keratinocyte stem cells in the bulge area and because of innumerous capillaries in this region. So far we have accomplished 45 transplantations from the hairy scalp, with a gender ratio of 27 female/18 male. The mean age was 63 years. In 15 cases we used V.A.C. fixation, in 30 cases Inadine as a primary wound dressing. V.A.C. was removed after 5 days, while primary dressing was changed after 2 days ( Figure 11, 12, 13 ). 
. SUMMARY
In the genetic studies we compared the SNP data of leg ulcer patients with healthy individuals for FGFR2-IIIb isoforms. The results showed that FGFR2-IIIb exhibits a lower expression level in venous leg ulcer patients, which will result in the impairment of reepithelisation, thus pathologic wound healing. The SNP data for the promoter region of the TNFα gene suggested a primary association with obesity and only a secondary association with leg ulceration.
We also set out to determine the expression abnormalities and/or gene polymorphisms of SDC4 and NRP1. We found out that SDC4 showed a significantly lower mRNA and protein expression levels in the uninvolved dermis of venous leg ulcer patients as compared to normal controls. In the case of NRP1 no expression abnormalities were detected.
In the cell culturing experiments, we established a chemical and artificial mitogen free autologous keratinocyte/melanocyte culturing technique. We developed a special culture media to suit the needs of melanocytes as well as keratinocytes. This method enables the preparation of autologous skin cell cultures suitable for the grafting of chronic wounds.
Furthermore and with the use of the hairy scalp as a donor site we established cultures that consisted primarily of keratinocytes stem cells. This autologous skin cell culture was successfully applied for the grafting of chronic leg ulcers with the Tissucol ® system.
With the knowledge of the culturing results, we developed a split skin grafting technique for the transplantation of chronic leg ulcers. The split skin grafts taken from the hairy scalp were used for grafting with V.A.C. fixation of the grafts on the wound bed. With the combination of the hairy scalp and the V.A.C. technique all the grafts attached and vitalized on the wound bed.
DISCUSSION
Genetic studies
Leg ulceration is a multifactorial disorder with several known and yet unknown environmental and genetic factors contributing to its etiology. Our genetic studies are restricted to a homogenic subgroup of venous leg ulcers. However the complexity of venous leg ulcer pathogenesis is increased by the fact that in the majority of the cases its development were excluded from the study. Venous leg ulcer patients were also screened for cardiac diseases (incidence was 49.1%), atherosclerosis (incidence was 20.4%) and autoimmune disorders (incidence was 5.1%). The study was approved by the Internal Review Board.
Written informed consent was obtained from all donors, and the study was conducted according to the Principles of the Declaration of Helsinki.
The importance of several putative genetic factors has been assessed in the homogenous group of venous leg ulcer patients such as the G1691A factor V Leiden mutation, G20210A prothrombin gene mutation, 2451 A/G polymorphism (SNP) of the FGFR2 gene and the -308 G/A SNP of the promoter region of the TNFα gene (Jebeleanu et al., 2001 , Hafner et al., 2001 Nagy et al., 2005 and 2007) . The studies were carried out using RT-PCR with TaqMan probes and RFLP techniques described in previous studies , Hafner et al., 2001 Nagy et al., 2005 and 2007 demonstrated previously that the -308 A/G SNP of the promoter region of the TNFα gene is a predisposing factor to venous leg ulcer development Nagy et al., 2007) . Further larger studies in different populations are needed to characterize the underlying genetic abnormalities in the mechanism of leg ulcer development and to work out costeffective techniques for the routine diagnostic assessments of the putative genetic factors and causative treatment options for these patients.
Local wound care studies
Several methods and several media formulations have been published over the years for the separation and subsequent culturing of human epidermal melanocytes and keratinocytes (Eisinger et al., 1982; Gilchrest et al., 1984; Hu et al., 1957) . With few exceptions, all methods used chemical mitogens to enhance cell growth. Co-cultures of melanocytes with keratinocytes in a melanocyte growth medium (MGM) supplemented with EGF, BPE, and FBS resulted in sufficient in vitro melanocyte growth without the need for chemical mitogens (Donatien et al., 1993) . The use of basic fibroblast growth factor (bFGF), endothelin-1 (ET-1) and α-melanocyte stimulating hormone (α-MSH) have also been reported to be able to replace the need for TPA and BPE in already established in vitro cultures of human neonatal melanocytes (Swope et al., 1995) . The culture system that we describe here is unique, in that relatively long term, pure melanocyte cultures, with cells derived from adult epidermis, that are never exposed to chemical mitogens, can be established easily. Although additional growth factor supplementation (e.g. EGF, BPE) increases cell proliferation, the use of serum is sufficient to establish and maintain the in vitro culture of these cells in our medium. We found autologous human serum (AHS) to be somewhat superior to FBS in supporting the in vitro melanocyte growth. Cells expanded in vitro in Mel-mix supplemented with autologous human serum allow autologous transplantation of cultured skin cells in chronic wounds and in vitiligo (Lontz et al., 1994; Olsson et al., 1993; Olsson et al., 1995) .
We offer a novel culturing technique to isolate and culture human epidermal melanocytes and keratinocytes in a chemical mitogen-free environment. With this method it is possible to easily establish pure human epidermal skin cell cultures in which melanocytes propagate sufficiently already in the early passages, when their pigmentation is not lost, therefore they can be transplanted to cover vitiligo lesions. Further work will show whether the in vitro shortening, which in turn reduces lifespan of the autograft, hence it is of outmost importance to use undifferentiated keratinocytes for autologous transplantation purposes (Counter et al., 2003) .
Stem cells and transit amplifying cells are characterized by expression of the transcription factor p63, a member of the p53 gene family. Recent data suggest that p63 has a role in initiating epithelial stratification during development and a role in maintaining the proliferative potential of basal keratinocytes in mature epidermis (Koster et al., 2004) . As soon as the transit amplifying cells cease proliferation, the expression of p63 is downregulated and the cells start to produce K1 and K10 keratines. Production of K1 and K10 keratines mirrors the commitment to differentiation and is among the earliest events in the program of cellular terminal differentiation (Eichner et al., 1990) . The proportion of p63 positive and K1/K10 negative cells in transplanted keratinocytes is important for both short and long term clinical outcomes.
We have shown that the epidermal cell suspension prepared from hairy scalp contains an abundance of undifferentiated keratinocytes as compared to conventional donor sites (groin, upper leg) . Considering that stem cells are more abundant in hair follicles, the use of hairy scalp as a donor site provides a keratinocyte culture rich in undifferentiated keratinocytes (Taylor et al., 2000) . Therefore, cell cultures prepared from hairy scalp skin specimens can proliferate to yield the required cell number for transplantation in a shorter period as compared to conventional donor sites. Furthermore, the hairy-scalp derived cells have longer lifespan and longer regenerative capacities. The results reported here suggest that keratinocytes and melanocytes isolated and cultured from hairy scalp donor sites are more suitable for autologous transplantation of chronic leg ulcers and burnt skin areas than grafts established from conventional donor sites. Like other epidermal keratinocytes, the cultured cells can be successfully frozen and stored for possible future transplantations, an advantage that should prove useful both for patient and clinician.
FUTURE ASPECTS
Chronic wound care grew up to be a separate discipline in modern medicine. We are presently at the start of turning anecdotal facts to evidence based medicine in wound care. The palette of wound care dressings is growing day by day making daily decisions harder and harder about local treatment. Besides new dressings, new and sophisticated autologous skin cell culturing and transplantation methods can also be used to treat these chronic wounds.
Despite the fact of the "best dressing for all wounds" appearing every now and than a true expert in wound care should never forget: without treating the underlying disease long term success is never achieved. In some cases treating the underlying disease is simply not enough:
we demonstrated, that in some patients there are well determined genetic abnormalities behind the existence of the chronic wound.
We truly believe that the success of chronic wound care lies in team approach with setting complex care strategies. The team always consists of an interdisciplinary medical team, the patient and patient's family. Communication and partnership is of outmost importance between these groups. The continuous motivation, setting realistic and achievable goals for both medical staff and patient is as important as proper local wound care.
Establishing all three pillars of chronic wound care paves the path to healed chronic ulcers. 
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